In the nation’s continuing battle to overcome opioid misuse and addiction, Huntsville’s Serina Therapeutics has won funding from the National Institutes of Health to support its research on a new one-dose painkiller for post-operative patients. The drug, SER-227, “is a polymer conjugate of buprenorphine that can be administered in the recovery room by a surgeon…
